Recently, under the news of "family stab" and "mandarin duck seal", many citizens inquired about the purchase of new crown drugs, testing supplies and even oximeters.
For this reason, our reporter investigated the online and offline markets again yesterday.
At present, it is reported that Pfizer's new crown oral drug naimatevir tablet/ritonavir tablet combination package (Paxlovid) has been put into use in Zhejiang, the price is 2300 yuan/box and it is included in the medical insurance.
Although the inclusion of medical insurance to reduce the burden of patients' expenses, some people in the industry believe that this price still exceeds the price of 1,000 yuan/box previously reported in the market; at the same time, the reporter noticed that some pharmacies in Guangzhou can swipe medical insurance cards. Purchase COVID-19 antigen self-test products.
Up to now, 4 new coronavirus antigen detection reagent products have been approved in Guangdong Province, which are produced by Shenzhen Huada Yinyuan, Guangzhou Wanfu Bio, Shenzhen Yirui Biotechnology Co., Ltd., Shenzhen Yahuilong Biotechnology Co., Ltd., etc. Developed by 4 companies.
Text/Guangzhou Daily All-Media Reporter Tu Duanyu Wen Jingtu/Guangzhou Daily All-Media Reporter Li Bo
The new crown oral drug Paxlovid is temporarily included in the payment scope of the medical insurance fund
The website of the National Medical Insurance Administration previously issued a notice to temporarily include Paxlovid in the scope of payment of the medical insurance fund.
The newly added naimatevir tablets/ritonavir tablets in the "Diagnosis and Treatment Plan (Trial Version 9)" shall be purchased by medical institutions at the price agreed between the enterprise and relevant departments, and the medical insurance department shall pay according to regulations.
It is reported that the US government purchase price of Paxlovid is about 530 US dollars for a five-day course of treatment, or about 3360 yuan.
It is reported that at present, the first batch of imported new crown oral drug "Nimatvir tablets/ritonavir tablets" (Paxlovid) has been used in many places.
The highly anticipated drug, which underwent emergency approval, import distribution, and medical insurance coverage in more than a month, is now starting to work.
It is understood that this Pfizer's small molecule oral drug Paxlovid is the new crown treatment drug with the best efficacy data at present, and has the advantages of convenient administration and relatively low price.
On the evening of March 23, the official website of the National Health and Health Commission issued a notice to adjust the indications of Paxlovid in the "New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" to "mild and common types within 5 days of onset and accompanied by progression to severe disease". "Adults with high risk factors", cancel the applicable population for adolescents (12-17 years old, weight ≥ 40kg).
The notice stated that this was an adjustment based on the instructions approved by the State Drug Administration when Paxlovid was approved.
Online purchase of medical insurance is not yet supported, but the unit price is reduced and stockpiles pay attention to the validity period
Whether it is possible to use a medical insurance card to purchase a new crown antigen self-test product has attracted much attention.
Recently, the "Notice on Effectively Doing a Good Job in the Current Epidemic Prevention and Control Medical Security" issued by the Office of the National Medical Security Administration proposed that the new coronavirus antigen detection reagents and corresponding detection items should be temporarily included in the province's basic medical insurance medical service item catalog according to procedures.
The relevant expenses incurred by the insured in the designated primary medical institutions shall be paid in accordance with the current regulations of the overall planning area, and the expenses of purchasing testing reagents in the designated retail pharmacies can be paid using personal accounts.
How is the implementation of the policy in Guangzhou?
The relevant person in charge of Jianmin Medicine told reporters that at present, the National Medical Insurance Administration has included antigen self-test products into the medical insurance catalogue, and the insured can use the medical insurance card to use the medical insurance personal account in the store to pay for the purchase.
In a Jianmin pharmaceutical store in Guangzhou, the reporter saw that many antigen self-test products were placed on the shelves, and the "New Coronavirus Antigen Detection Reagent Operation Notice" was posted on the wall.
According to the person in charge, customers can use antigen self-test products more accurately after reading the notice and watching the operation demonstration video.
It has been nearly two weeks since the new crown antigen self-test product was launched online.
According to relevant persons on the platform, at present, the online self-testing products of the new crown antigen have not yet supported the purchase of medical insurance.
On the 28th, the reporter found on an e-commerce platform that the unit price of a new crown antigen self-test product from some manufacturers has dropped to 9.9 yuan per person.
It is understood that the manufacturer's new crown antigen self-test box is priced at 69.5 yuan / box, 5 people / box, plus the platform's 20 yuan subsidy, it is 9.9 yuan for a single person.
The reporter searched multiple e-commerce and takeaway platforms and found that, compared with the just-release stage, the prices of the new coronavirus antigen self-test products currently on sale have been lowered, and the number of manufacturers and specifications that can be selected has also increased. Most manufacturers have launched 5 copies. , 10 servings, 20 servings and other specifications, the single serving is between 13 yuan and 18 yuan, but the price of the individually packaged product for 1 serving is about 24 yuan, and the product of the multi-serving specification is purchased. Cost-effective.
The reporter noticed that the new crown antigen self-test products have an expiration date, such as Wanfu and Jinwofu products, which are valid for 6 months.
There is no certificate for factory products with large price differences of online oximeters
When the epidemic prevention and control is in progress, the sales of household medical devices are gradually booming.
The reporter noticed that there are currently many brands of oximeters on the e-commerce platform for sale, with prices ranging from more than 10 yuan to more than 10,000 yuan, and the price difference is very large.
On an e-commerce platform, the top sales are household-grade oximeters priced in the range of 100 yuan to 200 yuan, and most of them are medical grade priced above 5,000 yuan.
The home oximeter sold online is small in size and easy to operate.
However, some users reported that after purchasing a 17 yuan oximeter, they found that the digital display was erratic, and the blood oxygen number felt insensitive.
The products sold by the factory store are not common mainstream brands. The price starts at 10 yuan. The reporter consulted the customer service of the store. The customer service said that the product only has instructions and no certification, and it belongs to health care products; while the reporter browsed in a domestic brand self-operated store and found that the On the product page of the brand home oximeter, the national medical device registration certificate of the product is displayed, and there are detailed instructions for use.
JD Health data shows that in the past 15 days, the search volume for products such as new crown antigen detection kits, N95 masks, protective clothing, alcohol sprays, temperature guns and other products has increased significantly.
Among them, N95 masks increased by 211% month-on-month, alcohol spray increased by 243% month-on-month, and protective clothing increased by 216% month-on-month, while the search volume of oximeters was relatively stable, and there was no significant increase.